Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
BMC Cancer
|
June 16, 2023
Personalized follow-up of circulating DNA in resected stage III/IV melanoma: PERCIMEL multicentric prospective study protocol
Lionnel Geoffrois, Alexandre Harlé, Nassim Sahki, et al.
Acta Dermato-Venereologica
|
April 13, 2018
Lower-limb Ulcers in Systemic Sclerosis: A Multicentre Retrospective Case-control Study
Gérôme Bohelay, Sophie Blaise, Pierre Levy, et al.
Immunotherapy
|
September 13, 2024
Symptomatic aseptic sinusitis induced by immune checkpoint inhibitors for metastatic melanoma treatment
Sofia Tzoumpa, Béatrice Villette, Florence Granel-Brocard, et al.
Archives of Dermatology
|
September 19, 2012
Clinical and sociodemographic characteristics associated with thick melanomas. A population-based, case-case study in France
Florent Grange, Coralie Barbe, Francois Aubin, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
January 29, 2011
Sentinel lymph node biopsy or nodal observation in melanoma: a prospective study of patient choices
Florent Grange, Eve Maubec, Coralie Barbe, et al.
JAMA Dermatology
|
August 16, 2013
Distinctive features of melanoma and its management in elderly patients: a population-based study in France
Dragos Ciocan, Coralie Barbe, Francois Aubin, et al.
Archives of Dermatology
|
May 21, 2008
Variations in management of stage I to stage III cutaneous melanoma: a population-based study of clinical practices in France
Florent Grange, Fabien Vitry, Florence Granel-Brocard, et al.
Archives of Dermatology
|
March 17, 2010
The role of circumstances of diagnosis and access to dermatological care in early diagnosis of cutaneous melanoma: a population-based study in France
Frédérique Durbec, Fabien Vitry, Florence Granel-Brocard, et al.
Melanoma Research
|
November 11, 2024
Real-life effectiveness on overall survival of continued immune checkpoint inhibition following progression in advanced melanoma: estimation from the Melbase cohort
Camille Macaire, Wendy Lefevre, Sophie Dalac, et al.
Journal of the American Academy of Dermatology
|
June 21, 2021
Late-onset adverse events of anti-PD1 therapy in melanoma patients: An observational study from MELBASE, a nationwide prospective cohort
Clémentine Carlet, Stéphane Dalle, Marie-Thérèse Leccia, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
BMC Cancer
|
June 16, 2023
Personalized follow-up of circulating DNA in resected stage III/IV melanoma: PERCIMEL multicentric prospective study protocol
Lionnel Geoffrois, Alexandre Harlé, Nassim Sahki, et al.
Acta Dermato-Venereologica
|
April 13, 2018
Lower-limb Ulcers in Systemic Sclerosis: A Multicentre Retrospective Case-control Study
Gérôme Bohelay, Sophie Blaise, Pierre Levy, et al.
Immunotherapy
|
September 13, 2024
Symptomatic aseptic sinusitis induced by immune checkpoint inhibitors for metastatic melanoma treatment
Sofia Tzoumpa, Béatrice Villette, Florence Granel-Brocard, et al.
Archives of Dermatology
|
September 19, 2012
Clinical and sociodemographic characteristics associated with thick melanomas. A population-based, case-case study in France
Florent Grange, Coralie Barbe, Francois Aubin, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
January 29, 2011
Sentinel lymph node biopsy or nodal observation in melanoma: a prospective study of patient choices
Florent Grange, Eve Maubec, Coralie Barbe, et al.
JAMA Dermatology
|
August 16, 2013
Distinctive features of melanoma and its management in elderly patients: a population-based study in France
Dragos Ciocan, Coralie Barbe, Francois Aubin, et al.
Archives of Dermatology
|
May 21, 2008
Variations in management of stage I to stage III cutaneous melanoma: a population-based study of clinical practices in France
Florent Grange, Fabien Vitry, Florence Granel-Brocard, et al.
Archives of Dermatology
|
March 17, 2010
The role of circumstances of diagnosis and access to dermatological care in early diagnosis of cutaneous melanoma: a population-based study in France
Frédérique Durbec, Fabien Vitry, Florence Granel-Brocard, et al.
Melanoma Research
|
November 11, 2024
Real-life effectiveness on overall survival of continued immune checkpoint inhibition following progression in advanced melanoma: estimation from the Melbase cohort
Camille Macaire, Wendy Lefevre, Sophie Dalac, et al.
Journal of the American Academy of Dermatology
|
June 21, 2021
Late-onset adverse events of anti-PD1 therapy in melanoma patients: An observational study from MELBASE, a nationwide prospective cohort
Clémentine Carlet, Stéphane Dalle, Marie-Thérèse Leccia, et al.
Page
of 4